SUMMARY A family is described in which three male members died in early infancy with severe thrombocytopenia and a fourth in adolescence with aplastic anaemia. One child was investigated in detail and shown to have amegakaryocytic thrombocytopenia, progressing to pancytopenia as a result of bone marrow hypoplasia. His associated congenital abnormalities differed from those described in Fanconi's aplastic anaemia, his chromosomes were normal, and the fetal haemoglobin level was 48 %. Amegakaryocytic thrombocytopenia is itself rare and the index case appears unique. It is suggested that this family has a previously undescribed X linked variety of amegakaryocytic thrombocytopenia.
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This paper describes a family in which four male members had constitutional aplastic anaemia. One child developed aplastic anaemia during adolescence, while the remaining three had a rapidly fatal form of amegakaryocytic thrombocytopenia, thought to be inherited in an X linked manner. The condition progressed in one of them, the index case, to aplastic anaemia. The clinical features of this latter child do not fit exactly into any of the syndromes described so far and he appears to be unique.
Received for publication 24 Hughes4 reclassified constitutional aplastic anaemia in 1974 and recorded five males (type III) and two females (type IV) with amegakaryocytic thrombocytopenia, but only the females had associated congenital abnormalities or a positive family history.
In view of the very few patients reported it is difficult to ascertain whether amegakaryocytic thrombocytopenia is a distinct entity or merely the initial presentation of Fanconi's anaemia or a non-Fanconi's familial aplastic anaemia. Several families have been described' where aplastic anaemia could not be attributed to Fanconi's anaemia. In five such families, however, no member had any associated congenital malformation.
Two males in the present family died of haemorrhage in infancy, almost certainly the result of amegakaryocytic thrombocytopenia, while the proband presented haematologically with amegakaryocytic thrombocytopenia but rapidly developed generalised bone marrow hypoplasia. His associated clinical features did not fit with either Fanconi's anaemia or the cases of familial aplastic anaemia described so far. Although he was short with developmental delay, the skeletal deformities were confined to an infantile scoliosis, there was no abnormality of the thumbs, and the pigmented naevus was not typical of the diffuse mottled pigmentation or caf&-au-lait spots described in Fanconi's anaemia. There were no chromosomal breaks or rearrangements in peripheral blood lymphocytes, usually regarded as one of the most characteristic laboratory findings in Fanconi's anaemia and reported in 82% of the two largest series studied.7 Another notable feature was the fetal haemoglobin level of 48.4%, significantly higher than that recorded in Fanconi's anaemia (2 6 to 21 .9 %),4 constitutional aplastic anaemia (3 to 15 %),8 or previously reported cases of amegakaryocytic thrombocytopenia (3.1 to 57 0%),4 (20.1 %).6
Heterozygotes with hereditary persistence of high fetal haemoglobin have values of 20 to 30 %, but no associated anaemia. However, as in the present case, there is an even distribution of fetal haemoglobin through the red cell population, in contrast to thalassaemia where a cell to cell variation occurs. The persistence of fetal erythropoiesis in association with aplastic anaemia supports the concept of abnormal stem cell function. ' 6 Most cases of constitutional aplastic anaemia demonstrate an autosomal recessive mode of inheritance, although one family with dominant inheritance has been described.9 A number of X linked disorders are associated with thrombocytopenia, including an X linked form of hereditary isolated thrombocytopenia, but this follows a benign course in the families reported. The X linked Wiskott-Aldrich syndrome and dyskeratosis congenita have distinctive clinical features.
The only satisfactory explanation of the genetics in the present family is that the aplastic anaemia of the adolescent child (IV.2) is quite unrelated to that of the index case and his two cousins. These latter three appear to have a previously undescribed X linked variety of amegakaryocytic thrombocytopenia, unique to this particular family. I am indebted to Dr C A Sieff for arranging the investigations carried out in the Department of Haematology at the Hospital for Sick Children, Great Ormond Street, London, and to Professor P S Harper for genetic advice. The manuscript was kindly typed by Mrs J M Storey. 
